CLINICAL_TRIALS
trial_result
· 2011-04-15
Clinical Trial Update: Proof of Activity Study of UR-63325 in Allergic Rhinitis Induced by Nasal Challenge [Phase 2]
Summary
Phase 2 proof-of-activity trial of UR-63325 for seasonal allergic rhinitis has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Palau Pharma S.L.U. | Conditions: Seasonal Allergic Rhinitis | Phase 2 | Status: COMPLETED